A Study to Look at How Safe NNC0268-0965 is in People With Type 2 Diabetes

NCT04136067 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: NNC0268-0965
DRUG: insulin glargine

Sponsor

Novo Nordisk A/S